ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LABS Life Science Reit Plc

44.10
-0.30 (-0.68%)
Last Updated: 14:51:13
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Life Science Reit Plc LSE:LABS London Ordinary Share GB00BP5X4Q29 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -0.30 -0.68% 44.10 1,384,835 14:51:13
Bid Price Offer Price High Price Low Price Open Price
44.10 45.00 44.40 44.00 44.40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Real Estate Investment Trust 15.71M -27.61M -0.0789 -5.59 154.35M
Last Trade Time Trade Type Trade Size Trade Price Currency
14:57:58 AT 8,011 44.10 GBX

Life Science Reit (LABS) Latest News

Life Science Reit (LABS) Discussions and Chat

Life Science Reit Forums and Chat

Date Time Title Posts
23/2/202416:22LIFE SCIENCE REIT144

Add a New Thread

Life Science Reit (LABS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:57:5844.108,0113,532.85AT
14:51:1344.107,3173,226.80AT
14:43:4744.008,4883,734.72AT
14:42:4644.0415,0006,606.00O
14:36:3044.001,516667.04AT

Life Science Reit (LABS) Top Chat Posts

Top Posts
Posted at 29/2/2024 08:20 by Life Science Reit Daily Update
Life Science Reit Plc is listed in the Real Estate Investment Trust sector of the London Stock Exchange with ticker LABS. The last closing price for Life Science Reit was 44.40p.
Life Science Reit currently has 350,000,000 shares in issue. The market capitalisation of Life Science Reit is £154,350,000.
Life Science Reit has a price to earnings ratio (PE ratio) of -5.59.
This morning LABS shares opened at 44.40p
Posted at 16/2/2024 08:11 by ghhghh
I've been buying in anticipation of superior growth potential from their more specialist strategy. Risks are how long it takes them to persuade the market that it's not offices and what does future demand look like for such a niche REIT.

Limited new build and rising replacement costs must bode well for future capital appreciation? Dividend cover a bit of a red herring at this price.
Posted at 15/2/2024 13:58 by cousinit
I've been kicking the tyres here and wonder if anyone has any views.

The discount and the yield are definitely on the credit side, along with an element of pain already taken to refinance to 2026.

On the debit side:
Rent guarantees on asset voids have now expired with limited new letting (esp Cambourne)

Rolling Stock Yard has high quality tenants but like Cambourne the WAULT is short to break. Also Gyroscope has stopped development of their lead asset so is there a chance they exercise break? (See Syncona results)

Feels that the slow transition of some of the office assets into labs/hybrid opens up the risk of the valuer getting the red pen out on the back of general office value declines, especially given that these were largely bought prior to rates rising. The new OTP leases are a definite positive but the asset has less effect than the chunkier London/Cambridge ones.
Posted at 14/2/2024 17:08 by jonwig
#134 - at the interim, the 1p dividend cost £3.5m, and net rental income was £6.6m. So that's decent, but earlier dividends were probably uncovered (as they weren't invested enough to earn rent). It will be clearer with the final results - probably end-March.

#135 - I think you've misunderstood. Their LABS shares were held in a client's account. The client has since taken his funds elsewhere. So he's either sold the shares or holds them with another asset manager. If the latter, he ought to be issuing an RNS saying so.
Posted at 13/2/2024 12:17 by parsons4
The other RNS this morning is the answer for the very weak share-price. Don't forget the advisors bought stock recently at over 60p I topped up this morning because I think they are too cheap.
Posted at 13/2/2024 10:58 by davebowler
Liberum
New lease at Oxford Technology Park for £20.1 per sq. ft.
Analyst: Joachim Klement

Mkt Cap £181m | Share price 51.6p | Prem/(disc) -42.5% | Div yield 7.8%

Event

Life Sciences REIT announced that it has fully let Building 5 at Oxford Technology Park, covering 57,000 sq. ft. to WAE Technologies. WAE is a technology and engineering provider to a range of sectros, including green energy, medical engineering, and automotive. WAE is part of Forrtescue, a listed Australian company which aalso has an investment fund that invests in a wide variety of businesses including spinouts from Oxford and Cambridge Universities.

WAE will pay an annual rent of £1.146 million, or £20.1 per sq. ft. for a ten-year term with a break at year five on half the space and a rent review at the end of the fifth year.

Liberum view

This lease continues the improvements in the Oxford Technology Park. Since acquiring the space, LABS has increased the average rent from £15 per sq. ft. to £19.2. At £20.1 per sq. ft. the new lease is in line with this improvement and will increase the occupancy rate. However, the average WAULT to break for the Oxford Technology Park is 10.8 years and WAULT to expiry is 13.2 years so the new lease will reduce the WAULT for this asset somewhat.
Posted at 31/12/2023 09:27 by saltwood
I saw news this morning that Novo Nordisk has secured space in London's Knowledge Quarter where LABS' Rolling Stock Yard is based. I did see that RSY has a vacant floor and wondered if we might have a nice RNS to greet us early in the New Year?!

hxxps://www.scrilnow.com/novo-nordisk-to-launch-ai-research-hub-in-londons-technology-district/
Posted at 25/9/2023 16:58 by jonwig
Here's the explanation -

The increase in shareholding outlined in this form has been driven by the all-share combination of Rathbones Group Plc with Investec Wealth & Investment Limited which completed on 21st September 2023.

It's happened with a few shares.
Posted at 19/9/2023 06:02 by jonwig
BlackRock went to 5.26 yesterday (or rather, last Friday).

It's also possible Thursday's H1 results have something of interest. Most likely there's some M&A activity in the wings: strategic review of the discount, sale of assets and liquidation, takeover bid, etc.

Science labs are a big shortage area, so the assets here should be very liquid. Latest NAV was 91.3p (Dec 31).
Posted at 27/6/2023 14:35 by bathcoup
" .... The SONIA reference rate on both facilities has been capped at 2.00% per annum until March 2025."

jonwig, with the SONIA being at 4.4288%, does LABS need to pay to get it capped at 2%?
Posted at 14/4/2023 09:23 by gbcol
Chrisdgb, I haven’t picked up on any upcoming investor events for LABS, have you got any details? TIA.

For good or bad (and it’s not good ATM), I’ve got a fairly substantial holding in LABS now. Next month’s divi is going to be very decent though.
Life Science Reit share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com